Estrella Immunopharma Inc吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
28 0 公告 Quarterly report [Sections 13 or 15(d)] Estrella Immunop资讯 05-15 04:36
34 0 公告 Current report, item 3.01 Estrella Immunop资讯 05-03 05:07
34 0 公告 Transition reports [Rule 13a-10 or 15d-10] Estrella Immunop资讯 03-26 04:42
28 0 公告 Current report, items 8.01 and 9.01 Estrella Immunop资讯 02-21 21:33
35 0 公告 Current report, items 8.01 and 9.01 Estrella Immunop资讯 02-20 19:34
40 0 公告 Statement of changes in beneficial ownership of se Estrella Immunop资讯 02-15 05:40
39 0 公告 Statement of changes in beneficial ownership of se Estrella Immunop资讯 02-15 05:40
61 0 公告 Securities to be offered to employees in employee Estrella Immunop资讯 12-24 03:49
57 0 公告 Notice of Effectiveness Estrella Immunop资讯 12-20 19:07
65 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 12-18 06:03
52 0 公告 Current report, item 8.01 Estrella Immunop资讯 12-17 05:03
476 0 公告 [Cover]SEC-generated letter Estrella Immunop资讯 12-17 00:00
470 0 公告 [Cover]Correspondence Estrella Immunop资讯 12-17 00:00
57 0 公告 Registration statement under Securities Act of 193 Estrella Immunop资讯 12-13 06:14
57 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 12-10 03:48
66 0 公告 Current report, items 1.01 and 9.01 Estrella Immunop资讯 12-06 22:17
56 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 11-27 21:48
71 0 公告 Current report, items 5.03 and 9.01 Estrella Immunop资讯 11-27 06:13
61 0 公告 Current report, item 3.01 Estrella Immunop资讯 11-26 05:09
60 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 11-19 06:29
62 0 公告 Quarterly report [Sections 13 or 15(d)] Estrella Immunop资讯 11-15 05:46
61 0 公告 Current report, items 5.02 and 9.01 Estrella Immunop资讯 11-08 07:38
67 0 公告 [Amend] Current report, items 1.01, 5.02, and 9.01 Estrella Immunop资讯 11-08 07:38
58 0 公告 [Amend] Annual report [Section 13 and 15(d), not S Estrella Immunop资讯 10-29 07:42
66 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 10-03 05:38
59 0 公告 Annual report [Section 13 and 15(d), not S-K Item Estrella Immunop资讯 09-27 19:52
68 0 今晚如果能到-10左右可以进 苍穹股道 09-17 21:31
66 0 公告 Initial statement of beneficial ownership of secur Estrella Immunop资讯 08-24 03:56
62 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 08-22 05:18
54 0 公告 Current report, items 5.02, 7.01, and 9.01 Estrella Immunop资讯 08-21 05:48
57 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 08-06 22:37
53 0 公告 Current report, items 8.01 and 9.01 Estrella Immunop资讯 08-06 19:59
72 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 07-03 04:00
64 0 公告 Current report, items 8.01 and 9.01 Estrella Immunop资讯 07-02 18:49
62 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 05-16 04:52
43 0 公告 Quarterly report [Sections 13 or 15(d)] Estrella Immunop资讯 05-15 19:22
52 0 公告 Current report, items 1.01 and 9.01 Estrella Immunop资讯 05-14 05:38
54 0 公告 Current report, items 7.01 and 9.01 Estrella Immunop资讯 04-10 18:32
66 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 03-11 19:00
44 0 公告 Current report, items 8.01 and 9.01 Estrella Immunop资讯 03-11 18:57
51 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 03-08 05:43
45 0 公告 Current report, items 1.01 and 9.01 Estrella Immunop资讯 03-07 19:28
82 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 02-16 19:37
74 0 公告 Quarterly report [Sections 13 or 15(d)] Estrella Immunop资讯 02-15 07:19
65 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 02-13 08:04
72 0 公告 Current report, items 4.01 and 9.01 Estrella Immunop资讯 02-02 23:19
63 0 公告 Current report, items 8.01 and 9.01 Estrella Immunop资讯 01-31 00:49
83 0 公告 Notice of Effectiveness Estrella Immunop资讯 12-29 19:27
67 0 公告 Prospectus [Rule 424(b)(3)] Estrella Immunop资讯 12-29 06:15
67 0 公告 [Amend] General form for registration of securitie Estrella Immunop资讯 12-18 19:43
113 0 公告 Quarterly report [Sections 13 or 15(d)] Estrella Immunop资讯 11-21 06:30
70 0 公告 Notification of inability to timely file Form 10-Q Estrella Immunop资讯 11-15 20:23
64 0 公告 [Amend] Current report, item 5.03 Estrella Immunop资讯 11-15 10:02
78 0 公告 [Amend] General form for registration of securitie Estrella Immunop资讯 11-14 07:43
76 0 公告 General statement of acquisition of beneficial own Estrella Immunop资讯 10-30 18:25
106 0 公告 General form for registration of securities under Estrella Immunop资讯 10-11 18:43
86 0 公告 Initial statement of beneficial ownership of secur Estrella Immunop资讯 10-11 09:04
91 0 公告 Initial statement of beneficial ownership of secur Estrella Immunop资讯 10-11 04:22
103 0 公告 Initial statement of beneficial ownership of secur Estrella Immunop资讯 10-11 04:22
80 0 公告 Initial statement of beneficial ownership of secur Estrella Immunop资讯 10-11 04:22
86 0 公告 Initial statement of beneficial ownership of secur Estrella Immunop资讯 10-11 04:22
89 0 公告 Initial statement of beneficial ownership of secur Estrella Immunop资讯 10-11 04:22
85 0 公告 Initial statement of beneficial ownership of secur Estrella Immunop资讯 10-11 04:22
93 0 公告 Current report, items 1.01, 2.01, 2.03, 3.01, 3.02 Estrella Immunop资讯 10-06 05:14
94 0 公告 Statement of changes in beneficial ownership of se Estrella Immunop资讯 10-06 04:27
84 0 公告 Notification filed by national security exchange t Estrella Immunop资讯 10-06 01:18
91 0 公告 Statement of changes in beneficial ownership of se Estrella Immunop资讯 10-03 04:12
74 0 公告 Statement of changes in beneficial ownership of se Estrella Immunop资讯 10-03 04:11
77 0 公告 Statement of changes in beneficial ownership of se Estrella Immunop资讯 10-03 04:11
83 0 公告 Statement of changes in beneficial ownership of se Estrella Immunop资讯 10-03 04:11
80 0 公告 Statement of changes in beneficial ownership of se Estrella Immunop资讯 10-03 04:11
85 0 公告 Statement of changes in beneficial ownership of se Estrella Immunop资讯 10-03 04:11
86 0 公告 Statement of changes in beneficial ownership of se Estrella Immunop资讯 10-03 04:10
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
郑重声明:用户在社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500